Shopping Cart 0
Cart Subtotal
USD 0

Lancet and Pen Needles Market Information: By Type (Push Button Safety Lancets, Pressure Activated Safety Lancets And Side Button Safety Lancets), Application (Insulin, Capillary Blood Sampling, Hormones, Skin Testing) End-User - Global Forecast Till 2027

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4450

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 6250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Lancet and Pen Needles Market Information: By Type (Push Button Safety Lancets, Pressure Activated Safety Lancets And Side Button Safety Lancets), Application (Insulin, Capillary Blood Sampling, Hormones, Skin Testing) End-User-Global Forecast Till 2027

Market Analysis

For obtaining blood samples, Lancets are used as alternative devices. Lancets are getting worldwide acknowledgment and acceptance because of its convenient features which provide an edge over the customary strategies for vein puncture. Some of the essential highlights of the safety lancets are painless vein cut, safety while using and easier handling. The safety lancets and its major applications include cholesterol test, capillary blood microsampling, HIV screening test, and hemoglobin (HBO) test, blood group test, allergy tests, coagulation tests, several other blood-based tests.

Various factors, for example, the positive repayment condition and government support in chosen nations, benefits of insulin pens over vials and syringes, innovative headways to needle and pain tension, increasing number of diabetic populaces, and different gatherings, meetings, and congresses to make pen needle awareness is required to drive the development of the pen needles market amid the forecast period (2017-2023). In any case, the hazard related with blood transfusion may influence the development of the global lancet and pen needles market contrarily.

Market Segmentation

The global lancet and pen needles market is divided on the basis of its type, end-user, application, and regional analysis. Based on its type, the global market is divided into lancets and pen needles. On the basis of its application, the global lancet and pen needles market is segmented into skin testing, insulin, hormones, capillary blood sampling, GLP, and others. Based on its end users, the market is segmented into medical institutions & diagnostic centers, hospitals & clinics, research & academic laboratories, home care & home diagnostics, and others.

Regional Analysis

Geographically, the global lancet and pen needles market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major Players

Some of the major industry players in the global lancet and pen needles market are B. Braun Melsungen AG, Becton Dickinson, Terumo Corporation, Sanofi, Bayer AG, F. Hoffmann-La Roche AG, Novo Nordisk A S, Owen Mumford Ltd, Eli Lilly and Company, Medtronic, Sarstedt AG & Co, Ypsomed Holding AG, Greiner Bio One, HTL-STREFA S.A, Abbott Laboratories, Improve Medical, Allison Medical, Inc., UltiMed, Inc., Artsana S.p.a., Perrigo Diabetes Care, VOGT MEDICAL, MedExel Co., Ltd, Simple Diagnostics, ARKRAY Inc., Stat Medical, Trividia Health, Terumo, among others.

READ MORE

Table Of Content

Scope

Table of Contents:

1 Report Prologue

1.1 Increasing awareness of lancet and pen needles:

1.2 Production of lancet and pen needles:

1.3 FDA Regulation for Lancet:

2 Market Introduction

2.1 Introduction

2.2 Scope of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

2.5 Market Structure

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing prevalence of diabetes

4.2.2 Growing incidence number of contagious and non-contagious diseases

4.2.3 Increasing inclination towards home healthcare

4.2.4 Improving Medical Device Regulation

4.3 Restraints

4.3.1 Risk associated with blood transfusion

4.3.2 Growing adoption of oral drug delivery systems, reuse of pen needles and infusion sets

4.4 Opportunities

4.5 Mega Trends:

4.6 Macroeconomic Indicators

?

5 Market Factor Analysis

5.1 Porter's Five forces Model

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.2.1 R&D

5.2.2 Manufacturing

5.2.3 Distribution & Sales

5.2.4 Post-sales Monitoring

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

6 Global Lancet And Pen Needles Market, By Type

6.1 Lancet

6.1.1 Regular Lancet

6.1.2 Safety Lancet

6.1.2.1 Push Button Safety Lancet

6.1.2.2 Pressure Activated Safety Lancet

6.1.2.3 Side Button Safety Lancet

6.2 Pen Needles

6.2.1 Standard Needles

6.2.2 Safety Needles

7 Global Lancet And Pen Needles Market, By Application

7.1 Insulin

7.2 Capillary Blood Sampling

7.3 Hormones

7.4 Glucose Like Peptide (GLP)

7.5 Skin Testing

8 Global Lancet And Pen Needles Market, By End User

8.1 Hospitals & Clinics

8.2 Diagnostic Centers & Medical Institutions

8.3 Home Care & Home Diagnostics

8.4 Research & Academic Laboratories

9 Global Lancet and Pen Needles Market, By Region

9.1 Introduction

9.2 Europe

9.2.1 Western Europe

9.2.1.1 Germany

9.2.1.2 France

9.2.1.3 U.K

9.2.1.4 Italy

9.2.1.5 SPAIN

9.2.1.6 Rest of Western Europe

9.2.2 Eastern Europe

9.3 Americas

9.3.1 North America

9.3.1.1 U.S.

9.3.1.2 Canada

9.3.2 South America

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 South Korea

9.4.5 Australia

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 UAE

9.5.2 Saudi Arabia

9.5.3 Kuwait

9.5.4 Qatar

9.5.5 Africa

10 Competitive Landscape

10.1 Introduction

10.1 Company Share Analysis

11 Company Profile

11.1 B. Braun Melsungen AG

11.1.1 Company Overview

11.1.2 Financials

11.1.3 Products

11.1.4 Strategy

11.1.5 Key Developments

11.2 Terumo Corporation

11.2.1 Company Overview

11.2.2 Financials

11.2.3 Products

11.2.4 Strategy

11.2.5 Key Developments

11.3 Becton Dickinson

11.3.1 Company Overview

11.3.2 Financials

11.3.3 Products

11.3.4 Strategy

11.3.5 Key Developments

11.4 Sanofi

11.4.1 Company Overview

11.4.2 Financials

11.4.3 Products

11.4.4 Strategy

11.4.5 Key Developments

11.5 F. Hoffmann-La Roche AG

11.5.1 Company Overview

11.5.2 Financials

11.5.3 Products

11.5.4 Strategy

11.5.5 Key Developments

11.6 Bayer AG

11.6.1 Company Overview

11.6.2 Financials

11.6.3 Products

11.6.4 Strategy

11.6.5 Key Developments

11.7 Novo Nordisk A S

11.7.1 Company Overview

11.7.2 Financials

11.7.3 Products

11.7.4 Strategy

11.7.5 Key Developments

11.8 Eli Lilly and Company

11.8.1 Company Overview

11.8.2 Financials

11.8.3 Products

11.8.4 Strategy

11.8.5 Key Developments

11.9 Owen Mumford Ltd

11.9.1 Company Overview

11.9.2 Financials

11.9.3 Products

11.9.4 Strategy

11.9.5 Key Developments

11.1 Medtronic

11.10.1 Company Overview

11.10.2 Financials

11.10.3 Products

11.10.4 Strategy

11.10.5 Key Developments

11.11 Ypsomed Holding AG

11.11.1 Company Overview

11.11.2 Financials

11.11.3 Products

11.11.4 Strategy

11.11.5 Key Developments

11.12 Sarstedt AG & Co

11.12.1 Company Overview

11.12.2 Financials

11.12.3 Products

11.12.4 Strategy

11.12.5 Key Developments

11.13 Greiner Bio One

11.13.1 Company Overview

11.13.2 Financials

11.13.3 Products

11.13.4 Strategy

11.13.5 Key Developments

11.14 Abbott Laboratories

11.14.1 Company Overview

11.14.2 Financials

11.14.3 Products

11.14.4 Strategy

11.14.5 Key Developments

11.15 HTL-STREFA S.A.

11.15.1 Company Overview

11.15.2 Financials

11.15.3 Products

11.15.4 Strategy

11.15.5 Key Developments

11.16 Improve Medical

11.16.1 Company Overview

11.16.2 Financials

11.16.3 Products

11.16.4 Strategy

11.16.5 Key Developments

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO's View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of lancet and pen needles Industry

13 Appendix

13.1 Discussion Blue Print


List Of Figure

List of Figures:

FIGURE 1 GLOBAL LANCET AND PEN NEEDLES MARKET, BY TYPE, 2016 (%)

FIGURE 2 GLOBAL LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2016 (%)

FIGURE 3 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2016 (%)

FIGURE 4 GLOBAL LANCETS AND PEN NEEDLES MARKET, BY REGION, 2016 (%)

FIGURE 5 GLOBAL LANCET AND PEN NEEDLES MARKET: MARKET STRUCTURE

FIGURE 6 RESEARCH PROCESS

FIGURE 7 PORTERS FIVE FORCES MODEL: GLOBAL LANCET AND PEN NEEDLES MARKET

FIGURE 8 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2016 & 2027 (USD MILLION)

FIGURE 9 GLOBAL LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2016 & 2027 (USD MILLION)

FIGURE 10 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2016 & 2027 (USD MILLION)

FIGURE 11 GLOBAL LANCET AND PEN NEEDLES MARKET: COMPANY SHARE ANALYSIS, 2016 (%)


List Of Table

List of Tables:

TABLE 1 GLOBAL LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 2 GLOBAL LANCET AND PEN NEEDLES MARKET, BY LANCET, 2014-2027 (USD MILLION)

TABLE 3 GLOBAL LANCET AND PEN NEEDLES MARKET, BY PEN NEEDLES, 2014-2027 (USD MILLION)

TABLE 4 GLOBAL LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2014-2027 (USD MILLION)

TABLE 5 GLOBAL LANCET AND PEN NEEDLES MARKET, BY INSULIN, 2014-2027 (USD MILLION)

TABLE 6 GLOBAL LANCET AND PEN NEEDLES MARKET, BY CAPILLARY BLOOD SAMPLING, 2014-2027 (USD MILLION)

TABLE 7 GLOBAL LANCET AND PEN NEEDLES MARKET, BY HORMONES, 2014-2027 (USD MILLION)

TABLE 8 GLOBAL LANCET AND PEN NEEDLES MARKET, BY GLUCOSE LIKE PEPTIDE (GLP), 2014-2027 (USD MILLION)

TABLE 9 GLOBAL LANCET AND PEN NEEDLES MARKET, BY SKIN TESTING, 2014-2027 (USD MILLION)

TABLE 10 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2014-2027 (USD MILLION)

TABLE 11 GLOBAL LANCET AND PEN NEEDLES MARKET BY HOSPITALS & CLINICS, 2014-2027 (USD MILLION)

TABLE 12 GLOBAL LANCET AND PEN NEEDLES MARKET BY DIAGNOSTIC CENTERS & MEDICAL INSTITUTIONS,

2014-2027 (USD MILLION)

TABLE 13 GLOBAL LANCET AND PEN NEEDLES MARKET BY HOME CARE & HOME DIAGNOSTICS, 2014-2027

(USD MILLION)

TABLE 14 GLOBAL LANCET AND PEN NEEDLES MARKET BY RESEARCH & ACADEMIC LABORATORIES,

2014-2027 (USD MILLION)

TABLE 15 EUROPE LANCET AND PEN NEEDLES MARKET, BY COUNTRY, 2014- 2027 (USD MILLION)

TABLE 16 EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 17 EUROPE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 18 EUROPE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 19 EUROPE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 20 EUROPE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 21 EUROPE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 22 WESTERN EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 23 WESTERN EUROPE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 24 WESTERN EUROPE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 25 WESTERN EUROPE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 26 WESTERN EUROPE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 27 WESTERN EUROPE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 28 GERMANY LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 29 GERMANY LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 30 GERMANY SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 31 GERMANY PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 32 GERMANY APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 33 GERMANY END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 34 FRANCE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 35 FRANCE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 36 FRANCE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 37 FRANCE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 38 FRANCE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 39 FRANCE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 40 U.K LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 41 U.K LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 42 U.K SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 43 U.K PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 44 U.K APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 45 U.K END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 46 ITALY LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 47 ITALY LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 48 ITALY SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 49 ITALY PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 50 ITALY APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 51 ITALY END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 52 SPAIN LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 53 SPAIN LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 54 SPAIN SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 55 SPAIN PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 56 SPAIN APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 57 SPAIN END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 58 REST OF WESTERN EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 59 REST OF WESTERN EUROPE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 60 REST OF WESTERN EUROPE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 61 REST OF WESTERN EUROPE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 62 REST OF WESTERN EUROPE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 63 REST OF WESTERN EUROPE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 64 EASTERN EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 65 EASTERN EUROPE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 66 EASTERN EUROPE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 67 EASTERN EUROPE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 68 EASTERN EUROPE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 69 EASTERN EUROPE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 70 AMERICAS LANCET AND PEN NEEDLES MARKET, BY REGION, 2014- 2027 (USD MILLION)

TABLE 71 AMERICAS LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 72 AMERICAS LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 73 AMERICAS SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 74 AMERICAS PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 75 AMERICAS APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 76 AMERICAS END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 77 NORTH AMERICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 78 NORTH AMERICA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 79 NORTH AMERICA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 80 NORTH AMERICA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 81 NORTH AMERICA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 82 NORTH AMERICA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 83 U.S. LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 84 U.S. LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 85 U.S. SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 86 U.S. PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 87 U.S. APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 88 U.S. END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 89 CANADA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 90 CANADA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 91 CANADA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 92 CANADA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 93 CANADA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 94 CANADA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 95 SOUTH AMERICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 96 OUTH AMERICA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 97 SOUTH AMERICA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 98 SOUTH AMERICA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 99 SOUTH AMERICA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 100 SOUTH AMERICA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 101 ASIA PACIFIC LANCET AND PEN NEEDLES MARKET, BY COUNTRY, 2014- 2027 (USD MILLION)

TABLE 102 ASIA PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 103 ASIA PACIFIC LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 104 ASIA PACIFIC SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 105 ASIA PACIFIC PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 106 ASIA PACIFIC APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 107 ASIA PACIFIC END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 108 JAPAN LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 109 JAPAN LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 110 JAPAN SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 111 JAPAN PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 112 JAPAN APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 113 JAPAN END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 114 CHINA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 115 CHINA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 116 CHINA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 117 CHINA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 118 CHINA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 119 CHINA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 120 INDIA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 121 INDIA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 122 INDIA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 123 INDIA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 124 INDIA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 125 INDIA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 126 SOUTH KOREA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 127 SOUTH KOREA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 128 SOUTH KOREA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 129 SOUTH KOREA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 130 SOUTH KOREA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 131 SOUTH KOREA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 132 AUSTRALIA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 133 AUSTRALIA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 134 AUSTRALIA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 135 AUSTRALIA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 136 AUSTRALIA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 137 AUSTRALIA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 138 REST OF ASIA PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 139 REST OF ASIA PACIFIC LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 140 REST OF ASIA PACIFIC SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 141 REST OF ASIA PACIFIC PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 142 REST OF ASIA PACIFIC APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 143 REST OF ASIA PACIFIC END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 144 THE MIDDLE EAST & AFRICA LANCET AND PEN NEEDLES MARKET, BY COUNTRY, 2014- 2027 (USD MILLION)

TABLE 145 THE MIDDLE EAST & AFRICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 146 THE MIDDLE EAST & AFRICA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 147 THE MIDDLE EAST & AFRICA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 148 THE MIDDLE EAST & AFRICA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 149 THE MIDDLE EAST & AFRICA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 150 THE MIDDLE EAST & AFRICA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 151 UAE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 152 UAE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 153 UAE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 154 UAE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 155 UAE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 156 UAE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 157 SAUDI ARABIA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 158 SAUDI ARABIA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 159 SAUDI ARABIA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 160 SAUDI ARABIA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 161 SAUDI ARABIA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 162 SAUDI ARABIA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 163 KUWAIT LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 164 KUWAIT LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 165 KUWAIT SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 166 KUWAIT PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 167 KUWAIT APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 168 KUWAIT END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 169 QATAR LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 170 QATAR LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 171 QATAR SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 172 QATAR PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 173 QATAR APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 174 QATAR END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 175 AFRICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 176 AFRICA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 177 AFRICA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 178 AFRICA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 179 AFRICA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 180 AFRICA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

Licence Rights

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

B. Braun Melsungen AG, Becton Dickinson, Terumo Corporation, Sanofi, Bayer AG, F. Hoffmann-La Roche AG, Novo Nordisk A S, Owen Mumford Ltd, Eli Lilly and Company, Medtronic, Sarstedt AG & Co, Ypsomed Holding AG, Greiner Bio One, HTL-STREFA S.A, Abbott Laboratories, Improve Medical, Allison Medical, Inc., UltiMed, Inc., Artsana S.p.a., Perrigo Diabetes Care, VOGT MEDICAL, MedExel Co., Ltd, Simple Diagnostics, ARKRAY Inc., Stat Medical, Trividia Health, Terumo

Lancet and Pen Needles Market Information: By Type (Push Button Safety Lancets, Pressure Activated Safety Lancets And Side Button Safety Lancets), Application (Insulin, Capillary Blood Sampling, Hormones, Skin Testing) End-User-Global Forecast Till 2027

Market Analysis

For obtaining blood samples, Lancets are used as alternative devices. Lancets are getting worldwide acknowledgment and acceptance because of its convenient features which provide an edge over the customary strategies for vein puncture. Some of the essential highlights of the safety lancets are painless vein cut, safety while using and easier handling. The safety lancets and its major applications include cholesterol test, capillary blood microsampling, HIV screening test, and hemoglobin (HBO) test, blood group test, allergy tests, coagulation tests, several other blood-based tests.

Various factors, for example, the positive repayment condition and government support in chosen nations, benefits of insulin pens over vials and syringes, innovative headways to needle and pain tension, increasing number of diabetic populaces, and different gatherings, meetings, and congresses to make pen needle awareness is required to drive the development of the pen needles market amid the forecast period (2017-2023). In any case, the hazard related with blood transfusion may influence the development of the global lancet and pen needles market contrarily.

Market Segmentation

The global lancet and pen needles market is divided on the basis of its type, end-user, application, and regional analysis. Based on its type, the global market is divided into lancets and pen needles. On the basis of its application, the global lancet and pen needles market is segmented into skin testing, insulin, hormones, capillary blood sampling, GLP, and others. Based on its end users, the market is segmented into medical institutions & diagnostic centers, hospitals & clinics, research & academic laboratories, home care & home diagnostics, and others.

Regional Analysis

Geographically, the global lancet and pen needles market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major Players

Some of the major industry players in the global lancet and pen needles market are B. Braun Melsungen AG, Becton Dickinson, Terumo Corporation, Sanofi, Bayer AG, F. Hoffmann-La Roche AG, Novo Nordisk A S, Owen Mumford Ltd, Eli Lilly and Company, Medtronic, Sarstedt AG & Co, Ypsomed Holding AG, Greiner Bio One, HTL-STREFA S.A, Abbott Laboratories, Improve Medical, Allison Medical, Inc., UltiMed, Inc., Artsana S.p.a., Perrigo Diabetes Care, VOGT MEDICAL, MedExel Co., Ltd, Simple Diagnostics, ARKRAY Inc., Stat Medical, Trividia Health, Terumo, among others.

READ MORE

Scope

Table of Contents:

1 Report Prologue

1.1 Increasing awareness of lancet and pen needles:

1.2 Production of lancet and pen needles:

1.3 FDA Regulation for Lancet:

2 Market Introduction

2.1 Introduction

2.2 Scope of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

2.5 Market Structure

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing prevalence of diabetes

4.2.2 Growing incidence number of contagious and non-contagious diseases

4.2.3 Increasing inclination towards home healthcare

4.2.4 Improving Medical Device Regulation

4.3 Restraints

4.3.1 Risk associated with blood transfusion

4.3.2 Growing adoption of oral drug delivery systems, reuse of pen needles and infusion sets

4.4 Opportunities

4.5 Mega Trends:

4.6 Macroeconomic Indicators

?

5 Market Factor Analysis

5.1 Porter's Five forces Model

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.2.1 R&D

5.2.2 Manufacturing

5.2.3 Distribution & Sales

5.2.4 Post-sales Monitoring

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

6 Global Lancet And Pen Needles Market, By Type

6.1 Lancet

6.1.1 Regular Lancet

6.1.2 Safety Lancet

6.1.2.1 Push Button Safety Lancet

6.1.2.2 Pressure Activated Safety Lancet

6.1.2.3 Side Button Safety Lancet

6.2 Pen Needles

6.2.1 Standard Needles

6.2.2 Safety Needles

7 Global Lancet And Pen Needles Market, By Application

7.1 Insulin

7.2 Capillary Blood Sampling

7.3 Hormones

7.4 Glucose Like Peptide (GLP)

7.5 Skin Testing

8 Global Lancet And Pen Needles Market, By End User

8.1 Hospitals & Clinics

8.2 Diagnostic Centers & Medical Institutions

8.3 Home Care & Home Diagnostics

8.4 Research & Academic Laboratories

9 Global Lancet and Pen Needles Market, By Region

9.1 Introduction

9.2 Europe

9.2.1 Western Europe

9.2.1.1 Germany

9.2.1.2 France

9.2.1.3 U.K

9.2.1.4 Italy

9.2.1.5 SPAIN

9.2.1.6 Rest of Western Europe

9.2.2 Eastern Europe

9.3 Americas

9.3.1 North America

9.3.1.1 U.S.

9.3.1.2 Canada

9.3.2 South America

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 South Korea

9.4.5 Australia

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 UAE

9.5.2 Saudi Arabia

9.5.3 Kuwait

9.5.4 Qatar

9.5.5 Africa

10 Competitive Landscape

10.1 Introduction

10.1 Company Share Analysis

11 Company Profile

11.1 B. Braun Melsungen AG

11.1.1 Company Overview

11.1.2 Financials

11.1.3 Products

11.1.4 Strategy

11.1.5 Key Developments

11.2 Terumo Corporation

11.2.1 Company Overview

11.2.2 Financials

11.2.3 Products

11.2.4 Strategy

11.2.5 Key Developments

11.3 Becton Dickinson

11.3.1 Company Overview

11.3.2 Financials

11.3.3 Products

11.3.4 Strategy

11.3.5 Key Developments

11.4 Sanofi

11.4.1 Company Overview

11.4.2 Financials

11.4.3 Products

11.4.4 Strategy

11.4.5 Key Developments

11.5 F. Hoffmann-La Roche AG

11.5.1 Company Overview

11.5.2 Financials

11.5.3 Products

11.5.4 Strategy

11.5.5 Key Developments

11.6 Bayer AG

11.6.1 Company Overview

11.6.2 Financials

11.6.3 Products

11.6.4 Strategy

11.6.5 Key Developments

11.7 Novo Nordisk A S

11.7.1 Company Overview

11.7.2 Financials

11.7.3 Products

11.7.4 Strategy

11.7.5 Key Developments

11.8 Eli Lilly and Company

11.8.1 Company Overview

11.8.2 Financials

11.8.3 Products

11.8.4 Strategy

11.8.5 Key Developments

11.9 Owen Mumford Ltd

11.9.1 Company Overview

11.9.2 Financials

11.9.3 Products

11.9.4 Strategy

11.9.5 Key Developments

11.1 Medtronic

11.10.1 Company Overview

11.10.2 Financials

11.10.3 Products

11.10.4 Strategy

11.10.5 Key Developments

11.11 Ypsomed Holding AG

11.11.1 Company Overview

11.11.2 Financials

11.11.3 Products

11.11.4 Strategy

11.11.5 Key Developments

11.12 Sarstedt AG & Co

11.12.1 Company Overview

11.12.2 Financials

11.12.3 Products

11.12.4 Strategy

11.12.5 Key Developments

11.13 Greiner Bio One

11.13.1 Company Overview

11.13.2 Financials

11.13.3 Products

11.13.4 Strategy

11.13.5 Key Developments

11.14 Abbott Laboratories

11.14.1 Company Overview

11.14.2 Financials

11.14.3 Products

11.14.4 Strategy

11.14.5 Key Developments

11.15 HTL-STREFA S.A.

11.15.1 Company Overview

11.15.2 Financials

11.15.3 Products

11.15.4 Strategy

11.15.5 Key Developments

11.16 Improve Medical

11.16.1 Company Overview

11.16.2 Financials

11.16.3 Products

11.16.4 Strategy

11.16.5 Key Developments

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO's View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of lancet and pen needles Industry

13 Appendix

13.1 Discussion Blue Print


List Of Figure

List of Figures:

FIGURE 1 GLOBAL LANCET AND PEN NEEDLES MARKET, BY TYPE, 2016 (%)

FIGURE 2 GLOBAL LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2016 (%)

FIGURE 3 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2016 (%)

FIGURE 4 GLOBAL LANCETS AND PEN NEEDLES MARKET, BY REGION, 2016 (%)

FIGURE 5 GLOBAL LANCET AND PEN NEEDLES MARKET: MARKET STRUCTURE

FIGURE 6 RESEARCH PROCESS

FIGURE 7 PORTERS FIVE FORCES MODEL: GLOBAL LANCET AND PEN NEEDLES MARKET

FIGURE 8 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2016 & 2027 (USD MILLION)

FIGURE 9 GLOBAL LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2016 & 2027 (USD MILLION)

FIGURE 10 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2016 & 2027 (USD MILLION)

FIGURE 11 GLOBAL LANCET AND PEN NEEDLES MARKET: COMPANY SHARE ANALYSIS, 2016 (%)


List Of Table

List of Tables:

TABLE 1 GLOBAL LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 2 GLOBAL LANCET AND PEN NEEDLES MARKET, BY LANCET, 2014-2027 (USD MILLION)

TABLE 3 GLOBAL LANCET AND PEN NEEDLES MARKET, BY PEN NEEDLES, 2014-2027 (USD MILLION)

TABLE 4 GLOBAL LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2014-2027 (USD MILLION)

TABLE 5 GLOBAL LANCET AND PEN NEEDLES MARKET, BY INSULIN, 2014-2027 (USD MILLION)

TABLE 6 GLOBAL LANCET AND PEN NEEDLES MARKET, BY CAPILLARY BLOOD SAMPLING, 2014-2027 (USD MILLION)

TABLE 7 GLOBAL LANCET AND PEN NEEDLES MARKET, BY HORMONES, 2014-2027 (USD MILLION)

TABLE 8 GLOBAL LANCET AND PEN NEEDLES MARKET, BY GLUCOSE LIKE PEPTIDE (GLP), 2014-2027 (USD MILLION)

TABLE 9 GLOBAL LANCET AND PEN NEEDLES MARKET, BY SKIN TESTING, 2014-2027 (USD MILLION)

TABLE 10 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2014-2027 (USD MILLION)

TABLE 11 GLOBAL LANCET AND PEN NEEDLES MARKET BY HOSPITALS & CLINICS, 2014-2027 (USD MILLION)

TABLE 12 GLOBAL LANCET AND PEN NEEDLES MARKET BY DIAGNOSTIC CENTERS & MEDICAL INSTITUTIONS,

2014-2027 (USD MILLION)

TABLE 13 GLOBAL LANCET AND PEN NEEDLES MARKET BY HOME CARE & HOME DIAGNOSTICS, 2014-2027

(USD MILLION)

TABLE 14 GLOBAL LANCET AND PEN NEEDLES MARKET BY RESEARCH & ACADEMIC LABORATORIES,

2014-2027 (USD MILLION)

TABLE 15 EUROPE LANCET AND PEN NEEDLES MARKET, BY COUNTRY, 2014- 2027 (USD MILLION)

TABLE 16 EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 17 EUROPE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 18 EUROPE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 19 EUROPE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 20 EUROPE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 21 EUROPE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 22 WESTERN EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 23 WESTERN EUROPE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 24 WESTERN EUROPE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 25 WESTERN EUROPE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 26 WESTERN EUROPE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 27 WESTERN EUROPE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 28 GERMANY LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 29 GERMANY LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 30 GERMANY SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 31 GERMANY PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 32 GERMANY APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 33 GERMANY END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 34 FRANCE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 35 FRANCE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 36 FRANCE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 37 FRANCE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 38 FRANCE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 39 FRANCE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 40 U.K LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 41 U.K LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 42 U.K SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 43 U.K PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 44 U.K APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 45 U.K END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 46 ITALY LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 47 ITALY LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 48 ITALY SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 49 ITALY PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 50 ITALY APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 51 ITALY END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 52 SPAIN LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 53 SPAIN LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 54 SPAIN SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 55 SPAIN PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 56 SPAIN APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 57 SPAIN END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 58 REST OF WESTERN EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 59 REST OF WESTERN EUROPE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 60 REST OF WESTERN EUROPE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 61 REST OF WESTERN EUROPE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 62 REST OF WESTERN EUROPE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 63 REST OF WESTERN EUROPE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 64 EASTERN EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 65 EASTERN EUROPE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 66 EASTERN EUROPE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 67 EASTERN EUROPE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 68 EASTERN EUROPE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 69 EASTERN EUROPE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 70 AMERICAS LANCET AND PEN NEEDLES MARKET, BY REGION, 2014- 2027 (USD MILLION)

TABLE 71 AMERICAS LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 72 AMERICAS LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 73 AMERICAS SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 74 AMERICAS PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 75 AMERICAS APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 76 AMERICAS END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 77 NORTH AMERICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 78 NORTH AMERICA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 79 NORTH AMERICA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 80 NORTH AMERICA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 81 NORTH AMERICA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 82 NORTH AMERICA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 83 U.S. LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 84 U.S. LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 85 U.S. SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 86 U.S. PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 87 U.S. APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 88 U.S. END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 89 CANADA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 90 CANADA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 91 CANADA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 92 CANADA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 93 CANADA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 94 CANADA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 95 SOUTH AMERICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 96 OUTH AMERICA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 97 SOUTH AMERICA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 98 SOUTH AMERICA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 99 SOUTH AMERICA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 100 SOUTH AMERICA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 101 ASIA PACIFIC LANCET AND PEN NEEDLES MARKET, BY COUNTRY, 2014- 2027 (USD MILLION)

TABLE 102 ASIA PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 103 ASIA PACIFIC LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 104 ASIA PACIFIC SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 105 ASIA PACIFIC PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 106 ASIA PACIFIC APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 107 ASIA PACIFIC END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 108 JAPAN LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 109 JAPAN LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 110 JAPAN SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 111 JAPAN PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 112 JAPAN APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 113 JAPAN END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 114 CHINA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 115 CHINA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 116 CHINA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 117 CHINA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 118 CHINA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 119 CHINA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 120 INDIA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 121 INDIA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 122 INDIA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 123 INDIA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 124 INDIA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 125 INDIA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 126 SOUTH KOREA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 127 SOUTH KOREA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 128 SOUTH KOREA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 129 SOUTH KOREA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 130 SOUTH KOREA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 131 SOUTH KOREA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 132 AUSTRALIA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 133 AUSTRALIA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 134 AUSTRALIA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 135 AUSTRALIA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 136 AUSTRALIA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 137 AUSTRALIA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 138 REST OF ASIA PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 139 REST OF ASIA PACIFIC LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 140 REST OF ASIA PACIFIC SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 141 REST OF ASIA PACIFIC PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 142 REST OF ASIA PACIFIC APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 143 REST OF ASIA PACIFIC END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 144 THE MIDDLE EAST & AFRICA LANCET AND PEN NEEDLES MARKET, BY COUNTRY, 2014- 2027 (USD MILLION)

TABLE 145 THE MIDDLE EAST & AFRICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 146 THE MIDDLE EAST & AFRICA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 147 THE MIDDLE EAST & AFRICA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 148 THE MIDDLE EAST & AFRICA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 149 THE MIDDLE EAST & AFRICA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 150 THE MIDDLE EAST & AFRICA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 151 UAE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 152 UAE LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 153 UAE SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 154 UAE PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 155 UAE APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 156 UAE END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 157 SAUDI ARABIA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 158 SAUDI ARABIA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 159 SAUDI ARABIA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 160 SAUDI ARABIA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 161 SAUDI ARABIA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 162 SAUDI ARABIA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 163 KUWAIT LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 164 KUWAIT LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 165 KUWAIT SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 166 KUWAIT PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 167 KUWAIT APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 168 KUWAIT END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 169 QATAR LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 170 QATAR LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 171 QATAR SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 172 QATAR PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 173 QATAR APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 174 QATAR END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 175 AFRICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 176 AFRICA LANCETS MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 177 AFRICA SAFETY MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 178 AFRICA PEN NEEDLES MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 179 AFRICA APPLICATION MARKET, BY TYPE, 2014-2027 (USD MILLION)

TABLE 180 AFRICA END USER MARKET, BY TYPE, 2014-2027 (USD MILLION)

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

B. Braun Melsungen AG, Becton Dickinson, Terumo Corporation, Sanofi, Bayer AG, F. Hoffmann-La Roche AG, Novo Nordisk A S, Owen Mumford Ltd, Eli Lilly and Company, Medtronic, Sarstedt AG & Co, Ypsomed Holding AG, Greiner Bio One, HTL-STREFA S.A, Abbott Laboratories, Improve Medical, Allison Medical, Inc., UltiMed, Inc., Artsana S.p.a., Perrigo Diabetes Care, VOGT MEDICAL, MedExel Co., Ltd, Simple Diagnostics, ARKRAY Inc., Stat Medical, Trividia Health, Terumo